China Regenerative Medicine International Ltd

Detailed Description

China Regenerative Medicine International Limited, an investment holding company, engages in the research and development of bio-medical and healthcare products, and medical techniques. It operates through Cell Products and Services, Cosmetic Products and Services, and Healthcare Products and Services segments. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. It also provides skincare and cosmetic products, including facial and eye creams, serums, moisturizing spray, tonic water, etc., under the Ascara brand. In addition, the company engages in the research and development, and applications of cell culture equipment and cell products; provision of cell-related outsourcing technical services; human cell separation, purification, cultivation, amplification, storage, and transportation; development and production of automated closed cell bioreactors; cellular therapy, cell storage, genetic testing, and biological agents manufacturing; cell preparation processes; technology platforms for clinical application transformation; developing of cell culture devices; separation, isolation, expansion, cryo-storage, and transportation of human cells; development and production of automated closed system cell expansion equipment. Further, it provides bio-engineered cornea, tissue engineering skin related products, and stem cell operation services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.